Divya Rana

Dr. Divya Rana

Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2017 in Journal of Perinatology
Verified
Journal Article
Closed access
DRDivya Rana
Divya Rana
BBB Bellflower
B Bellflower
JSJ Sahni
J Sahni
AKA J Kaplan
A J Kaplan
NON T Owens
N T Owens
RDR Dhanireddy
R Dhanireddy

6 February 2023 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
JLJoan Lien
Joan Lien
THTristan Hayes
Tristan Hayes
FLFeng Liu-Smith
Feng Liu-Smith
DRDivya Rana
Divya Rana
Objective To examine the effect of the COVID-19 pandemic on maternal substance abuse and neonatal outcomes. Study design Cross-sectional observational study of neonates admitted to the NICU and born to mothers with evidence of substance abuse pre-pandemic compared to during the COVID-19 pandemic. Result We noted a significant increase in fentanyl (12% vs. 0.6%, p < 0.001) and tobacco use (64% vs. 33%, p < 0.001) during the pandemic compared to pre-pandemic, including an increase in fentanyl use among mothers enrolled in opioid maintenance therapy (OMT) during the pandemic (32.3% vs. 1.5%, p < 0.001). There was a significant increase in preterm births (58% vs. 48%, p = 0.022) and lower birth weight (2315 ± 815 vs. 2455 ± 861 g, p = 0.049) during pandemic. Conclusion There was a significant increase in maternal fentanyl use during the pandemic, even with OMT enrollment, with an increase in preterm births and lower birth weights among infants born to mothers with substance use.

18 January 2021 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
RPRebecca Pollack
Rebecca Pollack
DRDivya Rana
Divya Rana
JPJohn Purvis
John Purvis
LPLeann Pollard
Leann Pollard
MPMassrour Pourcyrous
Massrour Pourcyrous

22 July 2019 in Journal of Neonatal-Perinatal Medicine
Verified
Journal Article
Closed access
PDF file
DRDivya Rana
Divya Rana
LPLeann Pollard
Leann Pollard
JRJonathan Rowland
Jonathan Rowland
RDRamasubbareddy Dhanireddy
Ramasubbareddy Dhanireddy
MPMassroor Pourcyrous
Massroor Pourcyrous
BACKGROUND: To describe amplitude-integrated encephalogram (aEEG) characteristics of neonates with neonatal abstinence syndrome (NAS). METHODS: This is a prospective observational study. Newborns exposed to prenatal opioids and their gestational matched controls were included. A single-channel aEEG was obtained using Olympic 6000 CFM monitor. The background activity (continuous/discontinuous), the amplitudes ( μV) and the presence of sleep-wake cycle (SWC) were documented. RESULTS: A total of 59 infants, 23 with NAS and 36 controls were enrolled. All aEEG were completed within 48 hours of life prior to initiation of treatment. Birth weight and gestational age were similar in both groups. An aEEG was abnormal (discontinuous pattern and/or absent SWC) in 78 % (18/23) of infants with NAS versus only 25% in control group (9/36), [OR 10.8, CI (2.7–46.5) P < 0.001]. 61% of infants with NAS had discontinuous pattern [OR 7.8, CI (2–32) P = 0.001] and 39% had absence of sleep-wake cycle [OR 7.1, CI (1.4–39.4) P = 0.007]. CONCLUSIONS: A majority of infants with NAS have abnormal aEEG activity.

29 October 2024 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
DRDivya Rana
Divya Rana
KGKan P. Gaston
Kan P. Gaston
LDLinda DeBaer
Linda DeBaer
MPMassroor Pourcyrous
Massroor Pourcyrous
This study aimed to evaluate the impact of in-utero illicit fentanyl exposure on neonatal outcomes, including neonatal opioid withdrawal syndrome (NOWS), length of stay (LOS), and treatment requirements.This study was conducted from March 2020 to December 2022, and focused on neonates born to mothers with opioid use or opioid use disorder (OUD). Maternal opioid use was identified through self-report or umbilical cord tissue (UCT) testing. Severe NOWS was defined as cases requiring pharmacological treatment. Statistical analyses included univariate comparisons, logistic regression, and generalized linear models to assess the associations between fentanyl exposure and neonatal outcomes.Forty-seven percent (75/159) of infants had in-utero fentanyl exposure. Fentanyl-positive mothers were older, 31 ± 5 years, compared to non-fentanyl mothers, 29 ± 5, p = 0.01. They were also less likely to receive prenatal care (p < 0.01) and had a higher number of polysubstance used, 5 ± 1 compared to non-fentanyl mothers, 3 ± 1, p < 0.01. Overall, infants exposed to fentanyl had a higher incidence of severe NOWS (odds ratio = 5.8, 95% confidence interval [CI]: 2.49–12.95, p < 0.01) and required earlier NOWS treatment initiation, 1 ± 1 day compared to non-exposed infants 3 ± 2 days, p < 0.01. In adjusted analysis, fentanyl exposure was associated with a nearly three-fold increased risk of NOWS (Mantel–Haenszel combined relative risk = 2.98, 95% CI: 1.94–4.57). Furthermore, fentanyl exposure led to longer LOS, with a 40% increase for preterm neonates (p < 0.01) and a 63% increase for full-term neonates (p < 0.01). Additionally, there was a significant correlation between log fentanyl concentration in umbilical cord tissue and cumulative morphine dose required for NOWS treatment, p = 0.001.Prenatal illicit fentanyl exposure is an independent and strong risk factor for severe NOWS presentation in newborns requiring extended hospital stays.

22 August 2022 in Journal of Neonatal-Perinatal Medicine
Verified
Journal Article
Closed access
DRDivya Rana
Divya Rana
KGK. Garde
K. Garde
MEM.T. Elabiad
M.T. Elabiad
MPM. Pourcyrous
M. Pourcyrous
BACKGROUND: Infants with in-utero exposure to opioids are at risk Neonatal Opioid Withdrawal Syndrome (NOWS) and non-pharmacological methods of care, like swaddling, quiet ambient environment are routinely recommended but are not systematically studied. We hypothesized that opioid exposed infants can tolerate whole body massage while hospitalized. METHODS: This is a prospective observational study (August 2017 to January 2019) and infants of mothers having a history of opioids use (OUD) were included. Infants received whole body massage for 30 minutes from birth till discharge home. Infants heart rate (HR), respiratory rate (RR), systolic (sBP) and diastolic blood pressure (dBP) were recorded prior to and at the end of massage session. RESULTS: The pilot study enrolled 30 infants. The mean birth weight and gestational age were 38±1 weeks and 2868±523 grams, respectively. All massage sessions were well tolerated. There was marked decrease in HR, systolic and diastolic BP and RR, (p < 0.01) in all study infants post massage, more profound among infants with NOWS (p < 0.01) than without NOWS. CONCLUSIONS: Whole body massage is very well tolerated by infants with in-utero opioid exposure. Infants with NOWS had marked decrease in their HR and BP from their baseline after massage.